CytoMed Therapeutics News

CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 24 10:16

CytoMed Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Glorious Finance Limited(38.89%),Choo Chee Kong(26.57%)

May 23 05:15

CytoMed Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

Apr 25 14:36

CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 24 15:19

CytoMed Therapeutics | 20-F: Registration statement / Annual report / Transition report

Apr 22 16:27

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 18 05:05

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 4 05:20

CytoMed Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-mDR Limited(11.59%)

Feb 14 15:04

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 29 06:03

CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 17, 2023 08:33

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 25, 2023 07:29

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 1, 2023 06:35

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 6, 2023 06:46

CytoMed Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Zeng Jieming(5.11%)

May 19, 2023 15:20

CytoMed Therapeutics | 20-F: Registration statement / Annual report / Transition report

May 1, 2023 16:26

CytoMed Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-mDR Limited(11.60%)

Apr 24, 2023 16:15

CytoMed Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Glorious Finance Limited(42.54%),Choo Chee Kong(28.86%)

Apr 21, 2023 14:16

CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 18, 2023 16:23

CytoMed Therapeutics | 424B4: Prospectus

Apr 17, 2023 15:05

CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Loh Yuin Han

Apr 17, 2023 05:18